A Fifty-fold Increase in the number of Children suffering from Gender Dysphoria reported in the media. On the 24th of…
Search Results: Children (162)
The Cass Review was politically motivated and not transparent, and it was criticised by health professionals worldwide. Continue Reading Are politicians trying to undermine the Cass Review – A Response
Gender Exploratory Therapy (GET) – Conversion Therapy explores the reasoning behind a patient’s gender dysphoria, but there are concerns that it is a conversion therapy technique that can inflict harm on trans youth by tying dysphoria to trauma, delaying access to gender-affirming care and lacking an estimated duration for the therapy.
Continue Reading Gender Exploratory Therapy (GET) – Conversion Therapy
Misinformation about transgender healthcare, often originating from US-based organisations, is being spread globally, targeting gender-affirming healthcare, and puberty blockers. This misinformation relies on false claims about the risks of puberty blockers, the alleged widespread regret of transitioning individuals (contradicted by a 95%-98% satisfaction rate), and the unfounded concept of Rapid Onset Gender Dysphoria (ROGD) purported to be a social contagion. Continue Reading Transgender Health – Misinformation
The Puberty Blocker Ban 2024 & why 5 of Europe’s Primary LGBT Organisations Condemn it Five of the most respected…
Gender Ideology – Definition for Briefing Notes – Overview: Over recent years, trans-hostile actors and right-wing members of the Conservative…
Jo Bartosch Journalist and Transphobe – Opinion Jo Bartosch describes herself as a journalist and feminist campaigner. She has written…
Our Year End Operational Review highlights TransLucent’s advocacy for the trans and non-binary community, including meetings with government officials to discuss healthcare and policy reform. The review also acknowledges financial challenges, celebrates the distribution of their report “TRANS: A Community Under Attack,” and outlines TransLucent’s position on the Cass Report, puberty blockers, and single-sex spaces.
Continue Reading TransLucent Year End Operational Review
TransLucent’s position statement argues against the ban on puberty blockers (GnRH analogues) for young trans people, citing insufficient evidence and potential bias in the Cass Review. Continue Reading TransLucent Puberty Blocker (GnRH Analogues) Position Statement
TransLucent appreciates the efforts made by Dr Hillary Cass and her team to improve the healthcare of gender-questioning children and…
